Filing Details

Accession Number:
0001209191-20-008293
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-11 16:16:38
Reporting Period:
2020-02-07
Accepted Time:
2020-02-11 16:16:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1117480 Chimerix Inc CMRX Pharmaceutical Preparations (2834) 330903395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780556 David Jakeman C/O Chimerix, Inc.
2505 Meridian Parkway, Suite 100
Durham NC 27713
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-02-07 2,290 $1.70 87,876 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to restricted stock unit awards granted on January 24, 2017, January 25, 2018 and January 23, 2019.